News & Updates
Filter by Specialty:
Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects
Compared with dapagliflozin, the glucagon-like peptide 1 liraglutide induces better lipid metabolism in patients with type 2 diabetes mellitus (T2DM), a recent study has found. However, this drug also comes with more adverse events than its sodium-glucose co-transporter 2 inhibitor comparator.
Liraglutide boosts lipid metabolism in T2DM, but comes with more side effects
02 Sep 2022
Vitamin D3 supplementation safe, well tolerated in overweight/obese prediabetics
Taking vitamin D3 supplementation at 4,000 IU per day does not produce any safety concern and is well tolerated among overweight and obese participants who are at risk for diabetes, reports a study.
Vitamin D3 supplementation safe, well tolerated in overweight/obese prediabetics
02 Sep 2022
Pandemic-fueled psych problems, fear of recurrence common among cancer patients
Psychological problems, such as post-traumatic stress disorder (PTSD), depression, and anxiety, are common among cancer patients during the COVID-19 pandemic, as were fears of disease progression or recurrence, a recent study has found.
Pandemic-fueled psych problems, fear of recurrence common among cancer patients
02 Sep 2022
Singapore-specific myocardial infarction risk score goes toe-to-toe with international tools
A myocardial infarction (MI) risk score derived from the Singapore Myocardial Infarction Registry (SMIR) performs just as well as international standards, such as the refined Global Registry of Acute Coronary Events (GRACE 2.0) score, according to a recent study.
